Clinical evidence supporting anti-inflammatory effects comes primarily from cardiovascular outcome trials in patients with type 2 diabetes
"GI AEs typically occur during initiation and uptitration, appearing as transient, mild-to-moderate symptoms." Laura Schalliol, PharmD, BCACP, BCGP, Professor of Pharmacy Practice In fact, 94% of adverse events reported in major clinical trials were mild or moderate in severity
CD36 localizes to the apical membrane of enterocytes found on the tips of jejunal villi (Hsieh et al., 2009)
Individuals with a history of nephrolithiasis should be counseled to avoid high oxalate foods, highly processed foods, and animal-source proteins [[112], [113], [114]]
So it's meant to be semaglutide or tirzepatide-like, but it's not the actual drug